Who is sponsoring NCT04068727?

NCT04068727 is sponsored by University of Massachusetts, Worcester.

What drugs are being tested in NCT04068727?

Interventions in NCT04068727: Clinical Pharmacist Intervention.

What condition does NCT04068727 study?

NCT04068727 studies Cardiovascular Diseases, Venous Thromboembolism, Atrial Fibrillation, Bleeding, Stroke.

Is NCT04068727 still recruiting?

NCT04068727 is currently completed. Last updated 20 February 2024.

Last reviewed 2024-02-20 · How we verify

NCT04068727

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LEAVE Safe With DOACs

Completed NA Last updated 20 February 2024

What this trial tests

NA trial testing Clinical Pharmacist Intervention in Cardiovascular Diseases in 561 participants. Completed in 14 September 2022.

Timeline

2 December 2019

Primary endpoint
1 December 2021

14 September 2022

Quick facts

Lead sponsor	University of Massachusetts, Worcester
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	561
Start date	2 December 2019
Primary completion	1 December 2021
Estimated completion	14 September 2022
Sites	1 location across United States

Drugs / interventions tested

Clinical Pharmacist Intervention — full drug profile →

Conditions studied

Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Venous Thromboembolism — all drugs for Venous Thromboembolism →
Atrial Fibrillation — all drugs for Atrial Fibrillation →
Bleeding — all drugs for Bleeding →

Sponsor

University of Massachusetts, Worcester

Who can join

18 and older, any sex, with Cardiovascular Diseases or Venous Thromboembolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Given the risks associated with direct oral anticoagulants (DOACs) and the lack of defined pathways for patients prescribed this class of medications, the study intervention has the potential for an enormous impact in preventing medication errors and improving the quality of care transition, patient knowledge, and adherence with DOAC therapy.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Occurrence of Ischemic Stroke in Patients With Atrial Fibrillation Receiving Non-Vitamin K Oral Anticoagulants: Causes and Prevention Strategies.
Bang OY, Park KM, Jeong DS. · · 2023 · cited 14× · PMID 36916018 · DOI 10.5853/jos.2022.03552
Multicomponent Pharmacist Intervention Did Not Reduce Clinically Important Medication Errors for Ambulatory Patients Initiating Direct Oral Anticoagulants.
Kapoor A, Patel P, Mbusa D, Pham T, et al · · 2023 · cited 4× · PMID 37758967 · DOI 10.1007/s11606-023-08315-z
Impact of a pharmacist intervention on DOAC knowledge and satisfaction in ambulatory patients.
Pham T, Patel P, Mbusa D, Kapoor A, et al · · 2023 · cited 4× · PMID 36510110 · DOI 10.1007/s11239-022-02743-0

Verify or expand the search:

Other trials of Clinical Pharmacist Intervention

Trials testing the same drug.

NCT05021393 — Clinical Pharmacists' Intervention on Pain Management in Cancer Patients · NA · completed
NCT04899960 — Drug-Related Problems in Neonatal Patients · NA · unknown

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other University of Massachusetts, Worcester trials

Trials by the same sponsor.

NCT07431528 — Dementia and Storytelling in Vietnam · NA · not yet recruiting
NCT07060664 — Study on Outcomes of Proximal Humerus Fractures · NA · not yet recruiting
NCT07520110 — Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis · Phase 3 · not yet recruiting
NCT06100809 — Does Fatigue Coaching Improve Functioning and Fatigue in Resident Night Shifts · NA · not yet recruiting
NCT06246539 — Impact of a Virtual Reality-based Mindfulness Program on Clinician Wellness · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04068727 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Worcester
Last refreshed: 20 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04068727.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing